Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537144 · ClinicalTrials.gov registry record · Phase 3
Acetaminophen vs Indomethacin in Treating hsPDA
A Phase 3 study, sponsored by University of Tennessee.
- Terminated
- Registry status
- Phase 3
- Development phase
- 37
- Enrollment target
NCT03537144 is a Phase 3 study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 37 participants.
The verdict
NCT03537144, a Phase 3 study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to see if acetaminophen (Tylenol) is as effective as indomethacin in closing patent ductus arteriosus in premature infants.
Interventions
- DRUG Acetaminophen
- DRUG Indomethacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03537144
The ClinicalTrials.gov registry entry for NCT03537144 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT03537144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03537144 about?
NCT03537144 is a clinical study titled "Acetaminophen vs Indomethacin in Treating hsPDA". The purpose of this study is to see if acetaminophen (Tylenol) is as effective as indomethacin in closing patent ductus arteriosus in premature infants.
What is the current status of trial NCT03537144?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 37 participants. The study started on 2016-06. Estimated completion is 2018-09.
What interventions are being tested in trial NCT03537144?
The interventions under investigation include: Acetaminophen (DRUG), Indomethacin (DRUG).
Who is sponsoring clinical trial NCT03537144?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.